Research and experimental development on natural sciences and engineering
NODE PHARMA AS
Revenue 2024
NOK 11.2m
Operating profit
NOK −358,000
Equity
NOK 2.8m
Incorporated
2021
Share capital
NOK 30,000
Key figures · 2024
Current ratio
1.49
Equity ratio
34.0%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -3.2% | |
| Net margin (%%) | -3.1% | |
| Return on assets (%%) | -4.4% | |
| Likviditet | ||
| Current ratio | 1.49 | |
| Working capital | 2.2m | |
| Soliditet | ||
| Equity ratio (%%) | 34.0% | |
| Debt-to-equity ratio | 1.94 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.